Oxemia 50 is a prescription medication, specifically an oral hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor, manufactured by Zydus Lifesciences to treat anemia in adults with chronic kidney disease (CKD). It works by stimulating natural erythropoietin production.